€90.28
0.47%
L&S, Jun 28, 10:53 pm CET
ISIN
FR0000120578
Symbol
SAN
Sector
Industry

Sanofi Share price

€89.94
+1.36 1.54% 1M
+0.68 0.76% 6M
+0.18 0.20% YTD
-8.90 9.00% 1Y
+1.35 1.53% 3Y
+14.48 19.18% 5Y
+12.82 16.62% 10Y
Paris, Closing price Fri, Jun 28 2024
ISIN
FR0000120578
Symbol
SAN
Sector
Industry

Key figures

Market capitalization €112.69b
Enterprise Value €122.71b
PER (TTM) P/E ratio 20.83
EV/FCF (TTM) EV/FCF 14.37
EV/Sales (TTM) EV/Sales 2.85
P/S ratio (TTM) P/S ratio 2.62
P/B ratio (TTM) P/B ratio 1.52
Dividend yield 4.18%
Last dividend (FY23) €3.76
Sales growth (TTM) Sales growth 0.17%
Turnover (TTM) Turnover €43.07b
EBIT (operating result TTM) EBIT €9.18b
Free cash flow (TTM) Free cash flow €8.54b
EPS (TTM) EPS €4.32
P/E ratio expected 15.85
P/S ratio expected 2.39
EV/Sales expected 2.60
Show more

Is Sanofi a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.

Sanofi Share analysis

Unlock scores for free

Analyst opinions

25 Analysts have issued a Sanofi forecast:

21x Buy
84%
3x Hold
12%
1x Sell
4%

Analyst opinions

25 Analysts have issued a Sanofi forecast:

Buy
84%
Hold
12%
Sell
4%

Financial data from Sanofi

Profit and loss account P&L | Balance sheet | Cash flow


TTM Annually
Dec '23
+/-
%
43,070 43,070
0% 0%
100%
- Direct costs 16,467 16,467
4% 4%
38%
26,603 26,603
2% 2%
62%
- Selling and administrative expenses 5,841 5,841
17% 17%
14%
- Research and development costs 6,728 6,728
0% 0%
16%
14,034 14,034
4% 4%
33%
- Depreciation and amortization 4,851 4,851
41% 41%
11%
EBIT (operating result) EBIT 9,183 9,183
8% 8%
21%
Net profit 5,400 5,400
35% 35%
13%

Figures in millions EUR.

Don't miss a thing! We will send you all news about the Sanofi share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Sanofi Share News

marktEINBLICKE
8 months ago
Für die Aktie des französischen Pharmakonzern Sanofi ging es zuletzt innerhalb weniger Tage um knapp 20 Prozent nach unten.
marktEINBLICKE
about 3 years ago
Das Biotech-Unternehmen Evotec hat wieder einmal eine neue Kooperation an Land gezogen. An der Börse könnte Evotec deshalb in Kürze einen Meilenstein setzen.
marktEINBLICKE
almost 4 years ago
Um die Entwicklung eines Corona-Impfstoffes voranzutreiben spannen mehrere Unternehmen und eigentliche Konkurrenten aus der Branche zusammen. Denn viele Vertreter der Industrie sind sich bewusst, dass sie eine riesige gesellschaftliche Verantwortung tragen.
More Sanofi News

Company profile

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Head office France
CEO Paul Hudson
Employees 87,994
Founded 1994
Website www.sanofi.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now